JAMA, cilt.326, ss.2478-2487, 2021 (SCI-Expanded)
IMPORTANCE The benefits of surfactant administration via a thin catheter (minimally invasive surfactant therapy [MIST]) in preterm infants with respiratory distress syndrome are uncertain.